Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F4E8T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,989
Award facts
- Contract value 100% obligated
- $23,989.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,989.02 delivery order to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits, with performance scheduled through January 13, 2026. This is a firm fixed-price, non-set-aside contract that represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The product being supplied—CIMZIA (certolizumab pegol)—is a TNF-alpha inhibitor used primarily for treating inflammatory conditions such as rheumatoid arthritis and Crohn's disease, supporting the military healthcare system's pharmaceutical supply requirements.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance location coincides with its corporate headquarters, and this delivery order demonstrates its ongoing capability to fulfill competitive federal procurement requirements for specialized pharmaceutical products. As a child entity of parent company Cencora, Inc., AmerisourceBergen leverages the broader IDC vehicle to efficiently supply essential medications and medical commodities to military treatment facilities and other federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F4E8T?
SPE2DR26F4E8T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4E8T worth?
The government has obligated $23,989 on SPE2DR26F4E8T.
Is contract SPE2DR26F4E8T an order under another contract?
Yes. SPE2DR26F4E8T is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E8T competed?
The extent of competition for SPE2DR26F4E8T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award